Mesoblast Ltd ADR (MESO) concluded trading on Thursday at a closing price of $16.76, with 3.97 million shares of worth about $66.52 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 139.09% during that period and on December 19, 2024 the price saw a gain of about 36.82%. Currently the company’s common shares owned by public are about 85.82M shares.
Stock saw a price change of 61.54% in past 5 days and over the past one month there was a price change of 54.90%. Year-to-date (YTD), MESO shares are showing a performance of 661.82% which increased to 690.57% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.61 but also hit the highest price of $13.74 during that period. The average intraday trading volume for Mesoblast Ltd ADR shares is 230.48K. The stock is currently trading 45.05% above its 20-day simple moving average (SMA20), while that difference is up 62.06% for SMA50 and it goes to 124.76% higher than SMA200.
Mesoblast Ltd ADR (NASDAQ: MESO) currently have 85.82M outstanding shares and institutions hold larger chunk of about 1.36% of that.
The stock has a current market capitalization of $1.91B and its 3Y-monthly beta is at 3.51. It has posted earnings per share of -$0.89 in the same period. It has Quick Ratio of 1.18 while making debt-to-equity ratio of 0.25. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MESO, volatility over the week remained 11.84% while standing at 6.11% over the month.
Stock’s fiscal year EPS is expected to rise by 24.80% while it is estimated to increase by 15.67% in next year. EPS is likely to grow at an annualized rate of 48.80% for next 5-years, compared to annual growth of 12.34% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Maxim Group on September 24, 2024 offering a Buy rating for the stock and assigned a target price of $12 to it. Stock get a Hold rating from Maxim Group on August 07, 2023.
